• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Pros & Cons of Actelion? Base..Bonus...Pipeline..Culture etc





If you are looking to get into rare disease- this is a great place to get in & grab 2 years of experience. Then move on to ANY other rare disease company for better. Better everything.

JnJ offers bottom rung pay. Absolutely bottom rung benefits. Last in the industry for time off. Bottom of the barrel fleet. Lowest incentive comp in rare disease & unachievable goals so no one ever gets paid the shitty target payout.

But- you will consistently hear about how profitable Actelion is & the record breaking revenue we're bringing in for the company.

Upside is that its a GREAT group of people to work with & once you get 2 years of rare disease experience- you'll have head hunters calling you with offers for 30-40% more money, exceptional health insurance for your family, upgraded fleet, great time off (example-year end shut down) and real sales awards.